Richerson, 1971 - Google Patents
Cutaneous basophil (Jones-Mote) hypersensitivity after" tolerogenic" doses of intravenous ovalbumin in the guinea pigRicherson, 1971
View PDF- Document ID
- 1516037787116954885
- Author
- Richerson H
- Publication year
- Publication venue
- The Journal of Experimental Medicine
External Links
Snippet
Cutaneous basophil hypersensitivity (CBH) was studied for tolerogenic requirements. Graded doses of intravenous ovalbumin (OA) were given to guinea pigs which were subsequently immunized appropriately to produce CBH, classic delayed hypersensitivity …
- 229940092253 Ovalbumin 0 title abstract description 65
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mota | The mechanism of anaphylaxis: I. Production and biological properties ofmast cell sensitizing'antibody | |
Cremer et al. | Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. | |
LoSpalluto et al. | The formation of macroglobulin antibodies. I. Studies on adult humans | |
Ovary et al. | Properties of guinea pig 7S antibodies II. Identification of antibodies involved in passive cutaneous and systemic anaphylaxis | |
Janković et al. | Role of the Thymus in Immune Reactions in Rats: I. The Immunologic Response to Bovine Serum Albumin (Antibody Formation, Arthus Reactivity, and Delayed Hypersensitivity) in Rats Thymectomized or Splenectomized at Various Times After Birth | |
Richerson | Cutaneous basophil (Jones-Mote) hypersensitivity after" tolerogenic" doses of intravenous ovalbumin in the guinea pig | |
Mota | Biological characterization of mouseearly'antibodies | |
Boros et al. | Delayed hypersensitivity, as manifested by granuloma formation, dermal reactivity, macrophage migration inhibition and lymphocyte transformation, induced and elicited in guinea pigs with soluble antigens of Schistosoma mansoni eggs | |
Malley et al. | Biologic properties of a non-precipitating antigen from timothy pollen extracts | |
Greisman et al. | Mechanisms of endotoxin tolerance III. The refractory state during continuous intravenous infusions of endotoxin | |
DK155174B (en) | PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC IMMUNOSUPPRESSIVE AGENT | |
Kuhns et al. | IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID: I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN | |
Wilkinson et al. | The role of mycobacteria and silica in the immunological response of the guinea-pig | |
Vischer et al. | Time of appearance and distribution of cells capable of secondary immune response following primary immunization | |
Borel et al. | Selective suppression of delayed hypersensitivity by the induction of immunologic tolerance | |
Perini et al. | The production of IgE and IgG1 antibodies in guinea-pigs immunized with antigen and bacterial lipopolysaccharides | |
Van Zwieten et al. | Experimental cell-mediated interstitial nephritis induced with exogenous antigens | |
Holland et al. | Haemagglutinating, precipitating and lymphocyte-stimulating factors of phytohaemagglutinin | |
NINNEMANN et al. | Isolation of immunosuppressive serum components following thermal injury | |
Salvin et al. | The specificity of allergic reactions III. Contact hypersensitivity | |
Cavelti | Autoimmunologic disease | |
Nussenzweig et al. | Differences in the electrophoretic mobilities of guinea pig 7S antibodies of different specificities | |
Mitchell et al. | Suppression of T cell-mediated cutaneous basophil hypersensitivity by serum from guinea pigs immunized with mycobacterial adjuvant. | |
Burnett et al. | Some immunological aspects of sea nettle toxins | |
James et al. | The effect of anti-lymphocytic antibody on the humoral immune response in different strains of mice: I. The response to bovine serum albumin |